43 results on '"Pfister, Christian"'
Search Results
2. LBA18 IMPACT OF TRANSIENT ANDROGEN DEPRIVATION THERAPY (ADT) WITH LEUPRORELIN LP 11.25 MG ON THE HISTOLOGICAL PROGRESSION OF INDOLENT PROSTATE CANCER (PC)–RESULTS OF A PHASE III TRIAL VERSUS ACTIVE SURVEILLANCE (AS)IMPACT OF TRANSIENT ANDROGEN DEPRIVATION THERAPY (ADT) WITH LEUPRORELIN LP 11.25 MG ON THE HISTOLOGICAL PROGRESSION OF INDOLENT PROSTATE CANCER (PC)–RESULTS OF A PHASE III TRIAL VERSUS ACTIVE SURVEILLANCE (AS)
3. Re: Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study
4. Final results of the phase III URO-BCG 4 multicenter study
5. MP47-18 SEXUAL OUTCOMES FOLLOWING TREATMENT OF ABDOMINAL AORTIC ANEURYSM, ENDOVASCULAR REPAIR VS. OPEN SURGERY: A PROSPECTIVE STUDY.
6. S&T-38 DIAGNOSIS PERFORMANCE OF CONTRAST-ENHANCED ULTRASONOGRAPHY AND MAGNETIC RESONANCE IMAGING FOR THE ASSESSMENT OF COMPLEX RENAL CYSTS: A PROSPECTIVE STUDY
7. Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma
8. MP63-15 THE SUBCLASSIFICATION OF PAPILLARY RENAL CELL CARCINOMA DOES NOT AFFECT ONCOLOGICAL OUTCOMES AFTER NEPHRON SPARING SURGERY.
9. MP63-12 NON CLEAR CELL RENAL CELL CARCINOMAS: ONCOLOGICAL OUTCOME AFTER NEPHRON SPARING SURGERY BASED ON AN INTERNATIONAL MULTICENTER STUDY
10. 1845 NATIONAL SURVEY ON THE USE OF PARTIAL NEPHRECTOMY IN FRANCE. DATA FROM THE MULTICENTER PROSPECTIVE NEPHRON STUDY
11. 569 PROSPECTIVE ANALYSIS OF RENAL TUMORS BIOPSY ACCURACY
12. 1411 ONCOLOGIC OUTCOMES AND EVOLUTION IN PATIENTS WITH PT0 DISEASE FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER. A MULTICENTRIC STUDY
13. 2064 RENAL CELL CARCINOMAS ARISING IN NATIVE KIDNEYS OF DIALYZED AND TRANSPLANT PATIENTS: ARE THEY DIFFERENT ENTITIES?
14. 505 CLINICO-PATHOLOGICAL AND OUTCOME FEATURES OF RENAL CELL CARCINOMAS IN PATIENTS WITH END STAGE RENAL DISEASE
15. 509 IS BASELINE RENAL FUNCTION A DECISION-MAKING CRITERION FOR CHOOSING AN ABLATIVE TECHNIQUE RATHER THAN A PARTIAL NEPHRECTOMY IN SMALL RENAL MASSES?
16. Re: DNA Microarray Expression Profiling of Bladder Cancer Allows Identification of Noninvasive Diagnostic Markers
17. THE USE OF NEPHRON SPARING SURGERY MAY FAVORABLY IMPACT THE RISK OF NON CANCER RELATED DEATH IN RENAL CELL CARCINOMA SURVIVORS
18. EARLY RENAL FUNCTION OUTCOMES FOLLOWING OPEN VS LAPAROSCOPIC PARTIAL NEPHRECTOMY: HOW DO THEY COMPARE?
19. NON-CANCER RELATED MORTALITY RATES IN EUROPEAN PATIENTS WITH T1A AND T1B RENAL CELL CARCINOMA
20. NEPHRON SPARING SURGERY (NSS) IS SUPERIOR TO RADICAL NEPHRECTOMY IN PRESERVING RENAL FUNCTION OUTCOME IN TUMORS LARGER THAN 4 CM
21. PARTIAL NEPHRECTOMY FOR RENAL MASSES: CAN WE APPLY THE QUALITY OF CARE CONCERN ADDRESSED BY THE UROLOGICAL COMMUNITY, TO THE EUROPEAN POPULATION?
22. NEPHRON-SPARING SURGERY VS. RADICAL NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA >7 CM. WITH NO EVIDENCE OF NODAL OR DISTANT METASTATSIS
23. PREDICTIVE FACTORS FOR LOCAL RECURRENCE AFTER NEPHRON SPARING SURGERY IN RENAL CELL CARCINOMA
24. TREATMENT OF LOCALIZED PROSTATE CANCER BY HIGH INTENSITY FOCUSED ULTRASOUND (HIFU); RESULTS OF THE FIRST FRENCH PROSPECTIVE STUDY ON PATIENTS NOT PREVIOUSLY TREATED: MINIMUM OF FIVE YEARS OF FOLLOW- UP
25. Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval
26. 1118: Impact of Histology on Cancer Control after Nephron Sparing Surgery for Renal Cell Carcinoma
27. 646: Morbidity of Nephron Sparing Surgery for Hilar Tumors
28. 1246: Nephron-Sparing Surgery does not Undermine Renal Cell Carcinoma-Specific Survival in Patients with PT3 Renal Cell Carcinoma
29. 915: Prognosis and Survival of Synchronous Bilateral Renal Cell Carcinoma: A Multicenter Experience
30. Usefulness of an Inline Radiofrequency Device in Renal Allograft Preserving Surgery
31. Pediatric Urinary Incontinence: Evaluation of Bladder Wall Wraparound Sling Procedure
32. Polymorphisms of the Human NRAMP1 Gene are Associated With Response to Bacillus Calmette-Guerin Immunotherapy for Superficial Bladder Cancer
33. 51: Morbidity and Clinical Outome of Nephron Sparing Surgery in Relation to Tumor Size and Indication
34. 91: Comparison Between Open and Laparoscopic Nephron Sparing Surgery. Results From a Multicenter Experience
35. Immunocyt Test Improves the Diagnostic Accuracy of Urinary Cytology: Results of a French Multicenter Study
36. LAPAROSCOPIC MANAGEMENT OF PARASTOMAL HERNIA IN TRANSILEAL URINARY DIVERSION
37. LAPAROSCOPIC MANAGEMENT OF PARASTOMAL HERNIA IN TRANSILEAL URINARY DIVERSION
38. EDITORIAL: NEW TRENDS FOR OPTIMAL MANAGEMENT OF BLADDER TUMORS
39. ADENOCARCINOMA ON RENAL ALLOGRAFT AS A COMPLICATION AT 5 YEARS
40. P53 MUTATIONS IN BLADDER TUMORS INACTIVATE THE TRANSACTIVATION OF THE P21 AND BAX GENES, AND HAVE A PREDICTIVE VALUE FOR THE CLINICAL OUTCOME AFTER BACILLUS CALMETTE-GUERIN THERAPY
41. SELECTIVE DETECTION OF INACTIVATING MUTATIONS OF THE TUMOR SUPPRESSOR GENE p53 IN BLADDER TUMORS
42. SELECTIVE DETECTION OF INACTIVATING MUTATIONS OF THE TUMOR SUPPRESSOR GENE p53 IN BLADDER TUMORS
43. Immunoassays in Monitoring Biotechnological Drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.